Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 454

1.

The landscape and lexicon of blinding in randomized trials.

Schulz KF, Chalmers I, Altman DG.

Ann Intern Med. 2002 Feb 5;136(3):254-9. No abstract available.

PMID:
11827510
2.

In the dark: the reporting of blinding status in randomized controlled trials.

Montori VM, Bhandari M, Devereaux PJ, Manns BJ, Ghali WA, Guyatt GH.

J Clin Epidemiol. 2002 Aug;55(8):787-90.

PMID:
12384193
3.

Practical aspects of randomization and blinding in randomized clinical trials.

Bridgman S, Engebretsen L, Dainty K, Kirkley A, Maffulli N; ISAKOS Scientific Committee.

Arthroscopy. 2003 Nov;19(9):1000-6. Erratum in: Arthroscopy. 2004 Mar;20(3):A14.

PMID:
14608321
4.

Intentional ignorance: a history of blind assessment and placebo controls in medicine.

Kaptchuk TJ.

Bull Hist Med. 1998 Fall;72(3):389-433. No abstract available.

PMID:
9780448
5.

The blind leading the blind: use and misuse of blinding in randomized controlled trials.

Miller LE, Stewart ME.

Contemp Clin Trials. 2011 Mar;32(2):240-3. doi: 10.1016/j.cct.2010.11.004. Epub 2010 Nov 9.

PMID:
21070890
6.

[Experimental studies].

Gili M, Lacalle JR, Velasco A.

Enferm Infecc Microbiol Clin. 1990 Jan;8(1):52-7. Review. Spanish. No abstract available.

PMID:
2095906
7.

Evaluating clinical research and bloodletting. (Seriously).

Ilfeld BM, Mariano ER.

Reg Anesth Pain Med. 2010 Nov-Dec;35(6):488-9. doi: 10.1097/AAP.0b013e3181f2c474. No abstract available.

PMID:
20975460
8.

Blinding during data analysis and writing of manuscripts.

Gøtzsche PC.

Control Clin Trials. 1996 Aug;17(4):285-90; discussion 290-3. No abstract available.

PMID:
8889343
9.

Blinding in randomized clinical trials: imposed impartiality.

Hróbjartsson A, Boutron I.

Clin Pharmacol Ther. 2011 Nov;90(5):732-6. doi: 10.1038/clpt.2011.207. Epub 2011 Oct 12.

PMID:
21993424
10.

Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.

Hróbjartsson A, Forfang E, Haahr MT, Als-Nielsen B, Brorson S.

Int J Epidemiol. 2007 Jun;36(3):654-63. Epub 2007 Apr 17.

PMID:
17440024
11.

Blinding in psychotherapy plus medication trials.

Smith EG, Mathur A.

Am J Psychiatry. 2006 Jul;163(7):1295. No abstract available.

PMID:
16816244
12.

Randomisation in clinical trials.

Beller EM, Gebski V, Keech AC.

Med J Aust. 2002 Nov 18;177(10):565-7. No abstract available.

PMID:
12429008
13.

The quest for unbiased research: randomized clinical trials and the CONSORT reporting guidelines.

Schulz KF.

Ann Neurol. 1997 May;41(5):569-73. No abstract available.

PMID:
9153517
14.

Why the 1948 MRC trial of streptomycin used treatment allocation based on random numbers.

Chalmers I.

J R Soc Med. 2011 Sep;104(9):383-6. doi: 10.1258/jrsm.2011.11k023. No abstract available.

15.

Assessing allocation concealment and blinding in randomised controlled trials: why bother?

Schulz KF.

Equine Vet J. 2005 Sep;37(5):394-5. No abstract available.

PMID:
16163939
16.

Randomized controlled trial design in rheumatoid arthritis: the past decade.

Strand V, Sokolove J.

Arthritis Res Ther. 2009;11(1):205. doi: 10.1186/ar2555. Epub 2009 Jan 30. Review.

17.
18.

Questioning the methodological superiority of 'placebo' over 'active' controlled trials.

Enkin MW.

Am J Bioeth. 2009 Sep;9(9):66-7. doi: 10.1080/15265160903098622. No abstract available.

PMID:
19998202
19.

Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.

Haahr MT, Hróbjartsson A.

Clin Trials. 2006;3(4):360-5. Review.

PMID:
17060210
20.

Redefining the randomized controlled trial in the context of acupuncture research.

Walji R, Boon H.

Complement Ther Clin Pract. 2006 May;12(2):91-6. Epub 2006 Mar 30. Review.

PMID:
16648085

Supplemental Content

Support Center